🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHow far away are we really from an oral option — my results so far

How far away are we really from an oral option — my results so far

MounjBrad Sun, Aug 4, 2024 at 1:20 PM 17 replies 2,175 viewsPage 1 of 4
This thread is more than 22 months old. Information may be outdated. Consider searching for more recent discussions.
MounjBrad
Member
278
890
Oct 2024
Kentucky
Aug 4, 2024 at 1:20 PM#1

On 25mg oral, four months in, and my results are closer to the low-dose injectable arm than to the numbers being quoted for 50mg.

The practical numbers: about 1% oral bioavailability, 30 minutes fasted before food, no more than 120ml of plain water, and coffee counts as food for this purpose.

What I am trying to establish is how much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly.

Numbers rather than impressions, if you have them.

50 20patPC_UT, Dr.DermMIA, fiona_VT and 47 others
Reply Quote Save Share Report
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Aug 4, 2024 at 1:28 PM#2

Answering the narrow version, because the broad one does not have a single answer. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

Correct me if the detail matters more than I have assumed.

49 19traveltech_sara, AttorneyGrant, DebRD_ATL and 46 others
Reply Quote Save Share Report
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
Aug 4, 2024 at 1:36 PM#3
LipidDoc_ATL said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

No disagreement with LipidDoc_ATL. One condition attached. Worth adding that the tablet is taken daily, so a missed dose costs far less than a missed weekly injection. That is a genuine advantage nobody lists.

48 18kevin_tulsa, Dr.PainCLE, mike_mealprep and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Aug 4, 2024 at 1:44 PM#4
MounjBrad said:
On 25mg oral, four months in, and my results are closer to the low-dose injectable arm than to the numbers being quoted for 50mg.

Can confirm the pattern MounjBrad describes. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

47 17PharmacoVig_BOS, SurmountFan_IN, PeptideChemSF and 44 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Aug 4, 2024 at 2:26 PM#5

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

46 16emily_PDX, Dr.SleepRoch, laura_annarbor and 43 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register